Loading...

IRadimed Corporation

IRMD•NASDAQ
Healthcare
Medical - Devices
$56.32
$-0.28(-0.49%)

IRadimed Corporation (IRMD) Stock Overview

Explore IRadimed Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.6/100

Key Financials

Market Cap716.1M
P/E Ratio36.08
EPS (TTM)$1.55
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Week$64.83
1 Month$62.59
3 Months$60.94
1 Year Target$62.27

IRMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IRadimed Corporation (IRMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $62.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.08 and a market capitalization of 716.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;